Skip to main
NICE

NICE Ltd (NICE) Stock Forecast & Price Target

NICE Ltd (NICE) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 17%
Buy 42%
Hold 42%
Sell 0%
Strong Sell 0%

Bulls say

NICE is a sound investment opportunity due to its strong performance in AI and self-service ARR, its recent large deal with Accenture in the healthcare sector, and the potential for growth in the customer support industry highlighted by the recent Fin acquisition by Salesforce. Its upcoming pure-play CX and AI business after the sale of Actimize will position the company well in the shift towards cloud-based and AI solutions in the customer support industry, despite skepticism from some customers regarding the current AI hype. However, potential risks such as competition and economic conditions should be monitored.

Bears say

NICE is a company with solid financial performance, however, there are several factors that raise concern for the future. While the company has a dominant position in the customer engagement and financial crime and compliance markets, competition is increasing and there are signs of slowing growth. Additionally, the company's strong reliance on the Americas market and potential macroeconomic deterioration could negatively impact revenue and cash flow in the future. Despite recent product developments and partnerships, there is a discount on the company's current valuation, which could suggest concerns about the long-term potential of their AI platform and ability to adapt to changing environments.

NICE Ltd (NICE) has been analyzed by 12 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 42% recommend Buy, 42% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of NICE Ltd and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About NICE Ltd (NICE) Forecast

Analysts have given NICE Ltd (NICE) a Buy based on their latest research and market trends.

According to 12 analysts, NICE Ltd (NICE) has a Buy consensus rating as of Aug 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $142.58, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $142.58, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

NICE Ltd (NICE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.